John B. Landis

Director, Inotiv, Inc.

Companies

EyePoint PharmaceuticalsBoard member Oct 29, 2018 to now¹
Inotiv, Inc.Board member Nov 23, 2009 to Aug 20, 2012²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

EyePoint Pharmaceuticals EYPT21,400 shares³$9.0K at $0.42Jan 5, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 5, 2025Exercised options 10,000 shares of EyePoint Pharmaceuticals³
Feb 9, 2023Exercised options 3,000 shares of EyePoint Pharmaceuticals⁴
Feb 9, 2022Exercised options 2,500 shares of EyePoint Pharmaceuticals⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREyePoint Pharmaceuticals, Board member
2
SEC EDGARInotiv, Inc., Board member
3
SEC EDGAREyePoint Pharmaceuticals shares after the filing of Jan 5, 2025
4
SEC EDGARForm 4 filed Feb 13, 2023
5
SEC EDGARForm 4 filed Feb 11, 2022